Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
What are the steps in personal finance planning? Knowing these can help you create a solid foundation for your financial future.
19,956 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Venture capital veteran Alfred Lin of Sequoia counters doom-laden SaaS forecasts, arguing AI-driven productivity and ...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A 23-year-old wiped out $60,000 in debt and now holds $204,000 in savings, illustrating how debt payoff can fuel long...
Cerebras has burst onto the Nasdaq scene, and Wall Street quickly weighed in with buys and cautious optimism. This ar...
Two consumer-staple giants posted results that intensify the dividend comparison between P&G and Colgate-Palmolive, a...
June inflation fell as energy and shelter costs cooled, pushing traders to delay expectations of a near-term Fed rate...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...
Nvidia has shown accelerating AI-driven demand that could push the stock higher. This article breaks down why the mar...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
A data-focused small-cap could ride the wave of real-time sports analytics and licensing revenue. This article breaks...